COLLAGEN SUPERDOSE - SOUTIEN MOBILITÉ
Food supplement declared in France, decision dated 6 February 2026
COLLAGEN SUPERDOSE - SOUTIEN MOBILITÉ (MINERVA Research Labs) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Boswellia serrata 37.5 mg per day, Piper nigrum 0.25 mg per day, Magnesium, Vitamin D, Glucosamine sulfate 2 KCl. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- MINERVA Research Labs
- Food business operator placing the product on the market
- MINERVA RESEARCH LABS LIMITED
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1 comprimé par jour
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Autre : contribue au fonctionnement normal des muscles et au métabolisme énergétique, Femmes enceintes, Sous antidiabétiques
- Objectives stated by the manufacturer (these are not authorised claims)
- Os, Autre : contribue au fonctionnement normal des muscles et au métabolisme énergétique
Declaration 353840, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Boswellia serrata Roxb. ex Colebr. | Gomme résine | Extrait sec hydroalcoolique | 37.5 mg |
| Piper nigrum L. | Fruit | Extrait sec alcoolique | 0.25 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Glucosamine sulfate 2 KCl | not declared |
| Collagène hydrolysé | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| magnesium bisglycinate | Magnesium | 250 mg | 300 mg |
| cholecalciferol | Vitamin D | 100 µg (4,000 IU) | 5 µg (200 IU) |
Additives
E551, E470b, E468, E341, E460
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux personnes diabétiques ou pré-diabétiques, asthmatiques ou traitées par anti-vitamine K. Déconseillé aux personnes dont l’alimentation est contrôlée pour le sodium, le potassium ou le calcium. Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas être utilisés comme substitut à une alimentation variée et équilibrée et à un mode de vie sain. Déconseillé aux femmes enceintes ou allaitante. En cas de traitements médicamenteux, demander conseil à un professionnel de santé. Tenir hors de portée des jeunes enfants. Conserver dans un endroit frais et sec, à l'abri de la lumière directe du soleil et de la chaleur. Réservé aux adultes.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Collagène hydrolysé
Read the warning, when it applies and the studies cited
Hydrolyzed Collagen
Route of administration: Oral
Cautions and warnings
Condition of application: Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Applies to products providing more than 2.8 g hydrolyzed collagen, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).
Sources cited by Health Canada (2)
- Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.
- Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease, 10th edition. Philadelphia (PA): Lippincott Williams and Wilkins, 2006.
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).
Sources cited by Health Canada (1)
- Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism 2000;30(2):87-99. PubMed Randomised trial
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : MINERVA Research Labs
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “COLLAGEN SUPERDOSE - SOUTIEN MOBILITÉ (MINERVA Research Labs): composition and regulation”, https://compoatlas.com/en/supplements/products/353840-collagen-superdose-soutien-mobilite, updated 15 November 2026.